Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
D000818:Animals; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2; D007694:Killer Cells, Natural / Q000276:immunology*; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2